Danaher Corp

  • Earnings Score
  • Moat Score
  • Safety Score
  • Final Score
  • Market Cap $170.50B
  • PE 44
  • Debt $18.72B
  • Cash $2.63B
  • EV $186.60B
  • FCF $5.01B

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$3.89B
EBIT$3.98B
ROE8%
ROA5%
FCF$5.01B
Equity$51.31B
Growth Stability84%
PE43.81
PEG4.79
PB3.32
P/FCF34.03
P/S8.51
Price/Cash0.02
Debt/Equity0.36
Debt/FCF3.74
Net Margins16%
Gross Margins60%
Op. Margins20%
Earnings CAGR12%
Sales Growth YoY-16%
Sales Growth QoQ1%
Sales CAGR6%
FCF CAGR12%
Equity CAGR11%
Earnings Stability0.56
Earnings Growth YoY-28%
Earnings Growth QoQ-10%
Earnings CAGR 5Y9%
Sales CAGR 5Y6%
FCF CAGR 5Y9%
Equity CAGR 5Y11%
Earnings CAGR 3Y-15%
Sales CAGR 3Y-15%
FCF CAGR 3Y-13%
Equity CAGR 3Y5%
Market Cap$170.50B
Revenue$20.03B
Dividend Yield0%
Payout Ratio20%
Assets$80.62B
Total Debt$18.72B
Cash$2.63B
Shares Outstanding722.2M
EV186.6B
Earnings Score78%
Moat Score79%
Safety Score89%
Final Score82%
Working Capital2.72B
Current Ratio1.37
Gross Profit$11.94B
Shares Growth 3y1%
Equity Growth QoQ3%
Equity Growth YoY-2%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

SEC Filings

Direct access to Danaher Corp (DHR) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 27
    • 10-Q Jun 28
    • 10-Q Mar 29
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 29
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jul 01
    • 10-Q Apr 01

Sector Comparison

How does Danaher Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Danaher Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 12%
Stability 56%
loading chart...

Danaher Corp Discounted Cash Flow

Fully customizable DCF calculator online for Danaher Corp .

= $119B
012345678910TV
fcf$5B$5.6B$6.3B$7.1B$8B$9B$10B$11B$13B$14B$16B$162B
DCF$5.1B$5.2B$5.3B$5.5B$5.6B$5.7B$5.8B$6B$6.1B$6.2B$62B
Value$119B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins13%16%15%14%13%16%16%21%23%20%16%
ROA-7%6%6%7%5%6%9%10%6%5%
ROE-14%11%9%9%10%9%14%14%9%8%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-4.295.073.752.916.623.913.142.753.483.74
Debt over Equity0.150.580.640.410.350.720.530.490.40.380.36
Growth Stability---88%95%100%100%100%100%84%84%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-3%-18%9%9%-10%24%32%7%-24%6%
Earnings YoY growth-29%-24%-2%6%11%19%79%13%-33%9%
Equity YoY growth-1%-3%14%7%7%31%14%11%7%11%
FCF YoY growth-1%-8%-3%18%-1%64%30%4%-22%9%